This study will describe the recovery process of patients undergoing cardiac surgery during the covid-19 pandemic. This will focus on hemodynamic failure and organ dysfunction after surgery. Capturing real-world data and sharing international experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care. This investigator-led, non-commercial, non-interventional does not collect any patient identifiable information.
Performing cardiac surgery in the context of SARS-CoV2 infection is potentially at risk of
marked post-operative hemodynamic failure (shock) due to the inflammatory reaction generated
by the surgery and the extracorporeal circulation associated with the viral infection. In
addition, in the absence of infection, 30-50% of patients will experience acute
post-operative respiratory failure due to the combined effects of extracorporeal circulation
and general anesthesia. The pulmonary tropism of the virus therefore is susceptible to
increase in post-operative respiratory impairment.
Thus, the infection is likely to favor the occurrence of post-operative shock but also to
aggravate respiratory failure and other post-operative organ failures.
Therefore, the investigators designed an observational study that aims at comparing two
groups of patients:
- Cardiac or thoracic surgery patients with a negative Covid-19 PCR pre-operatively and in
the 15 following days
- Cardiac or thoracic surgery patients with a positive Covid-19 PCR in the 15 days before
surgery
Other: No intervention
No description
Inclusion Criteria:
- Adults (age ≥18 years) undergoing cardiac or thoracic surgery
- With positive PCR in the 5 days before or after cardiac/thoracic surgery.
Exclusion Criteria:
- Minors
University Hospital
Nantes, France
Investigator: Mickael VOURC'H, MD
Contact: 0253482835
vourchm@gmail.com
Mickael VOURC'H, MD
0253482835
vourchm@gmail.com
Annick COULON
0253482835
bp-prom-regl@chu-nantes.fr